SQUIZZATO, ALESSANDRO
 Distribuzione geografica
Continente #
NA - Nord America 19.883
EU - Europa 8.207
AS - Asia 2.602
Continente sconosciuto - Info sul continente non disponibili 31
SA - Sud America 18
AF - Africa 8
OC - Oceania 7
Totale 30.756
Nazione #
US - Stati Uniti d'America 19.862
IT - Italia 3.235
UA - Ucraina 1.934
TR - Turchia 1.373
SE - Svezia 960
VN - Vietnam 616
DE - Germania 587
CN - Cina 525
FI - Finlandia 401
IE - Irlanda 390
GB - Regno Unito 268
BE - Belgio 183
FR - Francia 140
IN - India 39
EU - Europa 31
RU - Federazione Russa 30
CA - Canada 20
NL - Olanda 15
JP - Giappone 14
PT - Portogallo 13
RO - Romania 10
BR - Brasile 8
CL - Cile 6
ES - Italia 6
AT - Austria 5
CH - Svizzera 5
KR - Corea 5
SG - Singapore 5
AU - Australia 4
HU - Ungheria 4
MK - Macedonia 4
IL - Israele 3
MY - Malesia 3
NZ - Nuova Zelanda 3
PE - Perù 3
PL - Polonia 3
AE - Emirati Arabi Uniti 2
AL - Albania 2
DK - Danimarca 2
EG - Egitto 2
HK - Hong Kong 2
KZ - Kazakistan 2
MA - Marocco 2
MD - Moldavia 2
NG - Nigeria 2
NO - Norvegia 2
PH - Filippine 2
TW - Taiwan 2
AR - Argentina 1
AZ - Azerbaigian 1
BD - Bangladesh 1
BG - Bulgaria 1
CZ - Repubblica Ceca 1
GR - Grecia 1
KE - Kenya 1
KH - Cambogia 1
LK - Sri Lanka 1
LT - Lituania 1
MN - Mongolia 1
NP - Nepal 1
PK - Pakistan 1
PR - Porto Rico 1
RS - Serbia 1
SI - Slovenia 1
TH - Thailandia 1
TN - Tunisia 1
UZ - Uzbekistan 1
Totale 30.756
Città #
Fairfield 3.299
Milan 2.600
Woodbridge 2.390
Houston 1.743
Jacksonville 1.530
Chandler 1.396
Ashburn 1.322
Seattle 1.285
Ann Arbor 1.253
Wilmington 1.198
Cambridge 1.115
Izmir 657
Princeton 594
Dearborn 515
Nyköping 459
Dublin 390
Dong Ket 300
Brussels 178
San Diego 168
Como 167
San Mateo 154
Rome 149
Beijing 97
Hefei 69
Kocaeli 67
London 64
Düsseldorf 58
Kunming 52
Redmond 47
Nanjing 45
Boardman 35
Norwalk 34
Verona 34
Philadelphia 28
Jinan 27
Nanchang 27
Redwood City 22
Guangzhou 19
Falls Church 18
Helsinki 17
Ponte Lambro 17
Shenyang 14
Chicago 13
Tokyo 13
Zhengzhou 13
Besana In Brianza 12
Chiswick 12
Varese 12
Changsha 10
Fuzhou 10
Toronto 10
Chongqing 9
Dallas 9
Hangzhou 8
Ralingen 8
Chengdu 7
Hebei 7
Ningbo 7
Phoenix 7
Quzhou 7
Shaoxing 7
Wuhan 7
Islington 6
Jinhua 6
New York 6
São Paulo 6
Xian 6
Bergamo 5
Busto Arsizio 5
Casnate Con Bernate 5
Hanoi 5
Hanover 5
Indiana 5
Los Angeles 5
Stockholm 5
Trieste 5
Amsterdam 4
Auburn Hills 4
Bollate 4
Budapest 4
Cantu 4
Eppelborn 4
Esslingen am Neckar 4
Genoa 4
Istanbul 4
Monza 4
Mountain View 4
New Bedfont 4
San Francisco 4
San Severo 4
Taizhou 4
Vienna 4
Wallersheim 4
Andover 3
Bangalore 3
Berlin 3
Changchun 3
Cincinnati 3
Clearwater 3
Kuala Lumpur 3
Totale 24.005
Nome #
Brain and kidney, victims of atrial microembolism in elderly hospitalized patients? Data from the REPOSI study 236
Multimorbidity and polypharmacy in the elderly: lessons from REPOSI. 213
Risk of recurrence of unusual site venous thromboembolism 203
Choice and Outcomes of Rate Control versus Rhythm Control in Elderly Patients with Atrial Fibrillation: A Report from the REPOSI Study 188
Incidence rates and case fatality rates of portal vein thrombosis and Budd-Chiari Syndrome 183
Oral anticoagulant therapy in patients with mechanical heart valve and intracranial haemorrhage. A systematic review 181
Relationship between regulatory T cells subsets and lipid profile in dyslipidemic patients: A longitudinal study during atorvastatin treatment 181
Abdominal obesity and the risk of recurrent deep vein thrombosis 178
Heart failure and chronic kidney disease in a registry of internal medicine wards 178
PCSK9 inhibitors for treating dyslipidemia in patients at different cardiovascular risk: a systematic review and a meta-analysis 178
Optimal treatment duration of venous thrombosis 176
Mortality rate and risk factors for gastrointestinal bleeding in elderly patients 173
Impact of neutrophils to lymphocytes ratio on major clinical outcomes in patients with acute coronary syndromes: A systematic review and meta-analysis of the literature 172
Patient selection for thromboprophylaxis in medical inpatients 171
Subclinical hypothyroidism and deep venous thrombosis. A pilot cross-sectional study 169
Diagnostic accuracy of lung ultrasound for pulmonary embolism: a systematic review and meta-analysis. 168
Adherence to antibiotic treatment guidelines and outcomes in the hospitalized elderly with different types of pneumonia 168
Diagnosis and management of venous thromboembolism: Results of a survey on current clinical practice 167
Prognostic stratification of chronic heart failure in elderly population: are cardiopulmonary tests and BNP really valuable? 166
Gender-differences in disease distribution and outcome in hospitalized elderly: data from the REPOSI study. 166
Vitamin D Deficiency has a Negative Impact on Cetuximab-Mediated Cellular Cytotoxicity against Human Colon Carcinoma Cells 166
Diagnosis of overt and non-overt disseminated intravascular coagulation: A survey among experts and a call for action from the ISTH 164
Anticoagulant therapy for venous thromboembolism during pregnancy: a systematic review and a meta-analysis of the literature 162
Association between ABCG2 and ABCB1 genes and warfarin stability: a case-control study 162
Unsuspected pulmonary embolism in cancer patients: a narrative review with pooled data 162
Prevalence and Clinical History of Incidental, Asymptomatic Pulmonary Embolism: A Meta-Analysis 162
Imatinib discontinuation in chronic myeloid leukaemia patients with undetectable BCR-ABL transcript level: A systematic review and a meta-analysis 162
Effect of thromboprophylaxis with anticoagulant drugs on the incidence of arterial thrombotic events in medical inpatients: a systematic review 159
Prevention of venous thromboembolism and persistent vegetative state: a medical and an ethical issue 158
Treating patients with cancer and acute venous thromboembolism 158
Acquired von Willebrand syndrome in patients with overt hypothyroidism: a prospective cohort study 157
Incidence of chronic pulmonary hypertension in patients with previous pulmonary embolism 157
Incidence of cancer after a first episode of idiopathic venous thromboembolism treated with 3 months or 1 year of oral anticoagulation 157
Differential diagnosis of pulmonary embolism in outpatients with non-specific cardiopulmonary symptoms. 156
Pulmonary Embolism Severity Index Accurately Predicts Long-Term Mortality Rate In Patients Hospitalized For Acute Pulmonary Embolism 156
Cangrelor for the treatment of arterial thrombosis: pharmacokinetics/pharmacodynamics and clinical data 155
Prevalence and Risk Factors Associated with Use of QT-Prolonging Drugs in Hospitalized Older People 155
Time trends and case fatality rate of in-hospital treated pulmonary embolism during 11 years of observation in Northwestern Italy 154
Factors associated with anticoagulation prescription in elderly patients with atrial fibrillation 150
Balloon Pulmonary Angioplasty in Patients With Chronic Thromboembolic Pulmonary Hypertension - A Systematic Review and Meta-Analysis - 150
Applying EBM in clinical practice 149
A case report and literature review of portal vein thrombosis associated with Cytomegalovirus infection in immunocompetent patients 149
Imaging for the diagnosis of pulmonary embolism in very obese patients; a survey among internists and radiologists in Italy and the Netherlands 149
Statins and secondary prevention of ischemic and hemorrhagic stroke 148
Evaluation of the prevalence of severe hyperhomocysteinemia in adult patients with thrombosis who underwent screening for thrombophilia 148
Thrombosis Associated with Viral Hepatitis 148
Diagnostic accuracy of magnetic resonance imaging in patients with suspected pulmonary embolism: A bivariate meta-analysis 148
In vitro effects of Apixaban on 5 different cancer cell lines 148
Gender Difference in Efficacy and Safety of Nonvitamin K Antagonist Oral Anticoagulants in Patients with Nonvalvular Atrial Fibrillation or Venous Thromboembolism: A Systematic Review and a Meta-Analysis of the Literature 147
Post-operative arterial thrombosis with non-vitamin K antagonist oral anticoagulants after total hip or knee arthroplasty 146
Predictors of residual venous obstruction after deep vein thrombosis of the lower limbs: a prospective cohort study 144
Antiplatelet drugs for polycythaemia vera and essential thrombocythaemia 142
Presence of residual thromboemboli at least six months after a first episode of symptomatic pulmonary embolism: do perfusion scintigraphy and angio-computed tomography agree? 142
Non-vitamin K oral anticoagulants in patients with pulmonary embolism: a systematic review and meta-analysis of the literature 142
Hypothyroidism and acquired von Willebrand's syndrome: a systematic review 142
Adherence to antithrombotic therapy guidelines improves mortality among elderly patients with atrial fibrillation: insights from the REPOSI study 141
The 8th American college of chest physicians guidelines - A perspective on venous thromboembolism guidelines 141
Pulmonary embolism prognostic factors and length of hospital stay: A cohort study 141
Antithrombotic therapy and cancer. 139
Statins for acute ischemic stroke 139
sRAGE and early signs of cardiac target organ damage in mild hypertensives 139
The role of thrombolytic therapy in pulmonary embolism 138
How I treat splanchnic vein thrombosis 137
Certoparin for the treatment and prevention of thrombosis: pharmacological profile and results from clinical studies 136
Oral Anticoagulation Therapy in Heart Failure Patients in Sinus Rhythm: A Systematic Review and Meta-Analysis 136
Joint use of cardio-embolic and bleeding risk scores in elderly patients with atrial fibrillation 136
The effect of thyroid autoantibodies on warfarin stability 136
The initial phase of oral anticoagulation with warfarin in outpatients with deep venous thrombosis. 135
Prophylaxis of venous thromboembolism in elderly patients with multimorbidity 135
ESC position paper on cardiovascular toxicity of cancer treatments: challenges and expectations—comment 135
Subclinical hypothyroidism and deep venous thrombosis. A pilot cross-sectional study 134
Hospital Care of Older Patients With COPD: Adherence to International Guidelines for Use of Inhaled Bronchodilators and Corticosteroids 134
Antithrombotic and fibrinolytic drugs for retinal vein occlusion: a systematic review and a call for action. 133
Prevalence and Determinants of the Use of Lipid-Lowering Agents in a Population of Older Hospitalized Patients: the Findings from the REPOSI (REgistro POliterapie Società Italiana di Medicina Interna) Study 133
A systematic review on the effect of aspirin in the prevention of post-operative arterial thrombosis in patients undergoing total hip and total knee arthroplasty 133
Imatinib (IM) discontinuation in chronic myeloid leukemia (CML): A pharmacogenetic score for patients with durable complete molecular response (CMR) 133
JAK2V617F mutation for the early diagnosis of Ph- myeloproliferative neoplasms in patients with venous thromboembolism: a meta-analysis. 133
Anticoagulant therapy for venous thromboembolism during pregnancy: a systematic review and a meta-analysis of the literature: a reply to a rebuttal 132
Antiplatelet drugs for polycythaemia vera and essential thrombocythaemia 131
Thyroid dysfunction and effects on coagulation and fibrinolysis - a systematic review 130
Association between the metabolic syndrome, its individual components, and unprovoked venous thromboembolism: Results of a patient-level meta-analysis 130
Effects of mineralocorticoid receptor antagonists on the risk of thrombosis, bleeding and mortality: A systematic review and meta-analysis of randomized controlled trials 130
D-dimer testing in ischemic stroke and cerebral sinus and venous thrombosis. 125
The stigma of low opioid prescription in the hospitalized multimorbid elderly in Italy 125
Clopidogrel plus aspirin versus aspirin alone for preventing cardiovascular events 125
Patterns of infections in older patients acutely admitted to medical wards: data from the REPOSI register 124
The role of the metabolic syndrome in patients with provoked venous thromboembolic events 124
Drug–drug interactions involving CYP3A4 and p-glycoprotein in hospitalized elderly patients 124
An unusual case of cerebral vein thrombosis in a patient with giant cell arteritis 123
A new era for venous thromboembolism prevention in medical inpatients 123
Oral anticoagulant therapy in patients with mechanical heart valve and intracranial haemorrhage: A systematic review 123
Disability, and not diabetes, is a strong predictor of mortality in oldest old patients hospitalized with pneumonia 123
Alterations in coagulation and fibrinolysis after levothyroxine exposure in healthy volunteers: a controlled randomized crossover study. 122
Atypical case of Acute Coronary Syndrome due to Coronary-Pulmonary Steal Syndrome secondary to Pulmonary Embolism. 122
Increasing levels of free thyroxine as a risk factor for a first venous thrombosis: a case-control study 121
Decreased active von Willebrand factor level owing to shear stress in aortic stenosis patients. 121
Appropriateness of oral anticoagulant therapy prescription and its associated factors in hospitalized older people with atrial fibrillation 121
Gout, allopurinol intake and clinical outcomes in the hospitalized multimorbid elderly. 120
Evaluation of right ventricular function in patients with a previous episode of pulmonary embolism using tissue Doppler imaging. 120
Location of venous thrombosis in patients with FVL or prothrombin G20210A mutations: Systematic review and meta-analysis 120
Totale 14.825
Categoria #
all - tutte 80.475
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 80.475


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/20193.516 0 0 506 34 32 15 36 256 38 386 865 1.348
2019/20207.221 352 297 455 1.402 452 774 1.041 853 578 458 121 438
2020/20216.016 115 570 559 591 397 626 297 498 731 476 480 676
2021/20223.237 383 490 178 106 170 222 146 166 165 532 285 394
2022/20234.020 412 208 309 405 279 833 41 530 580 148 148 127
2023/20243.067 1.069 1.114 884 0 0 0 0 0 0 0 0 0
Totale 31.109